Insider Transactions in Q1 2025 at Dolby Laboratories, Inc. (DLB)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 05
2025
|
Ryan Nicholson VP, CAO and Corp. Controller |
SELL
Open market or private sale
|
Direct |
7,000
-19.04%
|
$588,000
$84.07 P/Share
|
|
Feb 05
2025
|
Ryan Nicholson VP, CAO and Corp. Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+16.0%
|
$231,000
$33.15 P/Share
|
|
Feb 04
2025
|
Simon Segars |
BUY
Grant, award, or other acquisition
|
Direct |
3,140
+6.77%
|
-
|
|
Feb 04
2025
|
Tony A Prophet |
BUY
Grant, award, or other acquisition
|
Direct |
3,140
+20.2%
|
-
|
|
Feb 04
2025
|
Emily Rollins |
BUY
Grant, award, or other acquisition
|
Direct |
3,140
+24.58%
|
-
|
|
Feb 04
2025
|
David Dolby |
BUY
Grant, award, or other acquisition
|
Direct |
3,140
+3.41%
|
-
|
|
Feb 04
2025
|
Peter C Gotcher |
BUY
Grant, award, or other acquisition
|
Direct |
3,140
+7.16%
|
-
|
|
Feb 04
2025
|
Avadis Tevanian |
BUY
Grant, award, or other acquisition
|
Direct |
3,140
+50.0%
|
-
|
|
Jan 30
2025
|
Mark Andrew Sherman EVP, Gen. Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
40,000
-21.63%
|
$3,360,000
$84.5 P/Share
|
|
Jan 30
2025
|
Mark Andrew Sherman EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+28.09%
|
$2,480,000
$62.32 P/Share
|
|
Jan 30
2025
|
Emily Rollins |
SELL
Open market or private sale
|
Direct |
1,000
-13.35%
|
$84,000
$84.9 P/Share
|